About
Linearis Ventures is pioneering and supporting discoveries to prevent, detect and cure diseases through direct investments in innovative life sciences companies. Linearis brings together a team of seasoned experts in biomarker discovery, drug development, BioPharma executives, healthcare innovators, the co-father of modern AI and winner of the A.M. Turing Prize, Dr Yoshua Bengio as well as the curator of the Human Metabolome Database, Dr David Wishart. To fundamentally transform our healthcare systems and improve patient care, we must provide novel, non-invasive and easily accessible modalities for better diagnosis, prediction of health status, optimization of treatments and monitoring. Integrated into the VC fund, Linearis Labs' AI-driven differentiating offering is unique in generating disease signatures tailored to elucidate causal relationships underlying human omics and diseases. Its omic signature AI-tailored approach to cancer, diabetes, infectious diseases, NASH and other chron
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 686 investors are based in Montréal, Quebec, Canada.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Stages
- growth
- Sectors
- healthtech
- Location
- Montréal, Canada
Contact Information
Find more investors like Linearis
Search Investors